US OptionsDetailed Quotes
COST241213P955000
- 0.01
- -4.44-99.78%
15min DelayClose Dec 13 16:00 ET
2.95High0.01Low
1.52Open4.45Pre Close608 Volume834 Open Interest955.00Strike Price13.01KTurnover587.77%IV3.47%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.0026Delta0.0006Gamma98935.00Leverage Ratio-24.8988Theta0.0000Rho-260.23Eff Leverage0.0002Vega
Costco Stock Discussion
Sign in to post a comment
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...
+2
1
1
1
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drug...
+2
$Costco (COST.US)$ possible 1011 today?
2
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Costco (COST.US)$ hahaha people short Costco is running away.
1
Stock futures were higher premarket after markets gave back some recent gains in the previous session. Tech stocks seem to be regaining strength. Let’s see if Nasdaq can close back above the milestone level of 20,000.
Meanwhile, sticky and persistent inflation could force Fed to re-consider their rate cut campaign next year. But that’s for 2025. Next week’s FOMC meeting will likely see the Fed cutting interest rate by 25 basis points again – probably setting the market up for ...
Meanwhile, sticky and persistent inflation could force Fed to re-consider their rate cut campaign next year. But that’s for 2025. Next week’s FOMC meeting will likely see the Fed cutting interest rate by 25 basis points again – probably setting the market up for ...
From YouTube
6
1
$Costco (COST.US)$ getting absolutely shafted on this nonsense
$Costco (COST.US)$ sian. this is going to the shitters for sure
As 2024 wraps up, U.S. stocks have seen a robust rally, with the $S&P 500 Index (.SPX.US)$ climbing over 26% year-to-date. This surge was driven by the AI boom and strategic plays in rate cuts, Trump-related trades, and recession hedges, each taking the spotlight at different times.
AI advertising firm $Applovin (APP.US)$ led gains with an almost 750% rise. AI data analytics company $Palantir (PLTR.US)$ jumped more than 320%, w...
AI advertising firm $Applovin (APP.US)$ led gains with an almost 750% rise. AI data analytics company $Palantir (PLTR.US)$ jumped more than 320%, w...
63
2
62
$Costco (COST.US)$ no meat on bone anymore.. this is a 750 company. hype has taken over
2
No comment yet
10xStockPicks OP : This is the correctly edited research report. Previous article has a few typos. Special thanks to Fund manager John for his notes. Please do your own research. I firmly believe ESPR will be a solid bet.